Raporty finansowe: Rachunek zysków i strat
BAY (BAYER)
122.00+10.86(+9.77%)
BAYER AG
TENDENCJE NEGATYWNE
Przychody ze sprzedaży: spadek o 12.00% r/r |
Zysk ze sprzedaży: spadek o 7.56% r/r |
Zysk operacyjny (EBIT): spadek o 4.33% r/r |
EBITDA: spadek o 10.42% r/r |
Zysk przed opodatkowaniem: spadek o 8.54% r/r |
Zysk netto: spadek o 15.60% r/r |
2011/Q1 (mar 11) | 2012/Q1 (mar 12) | 2013/Q1 (mar 13) | 2014/Q1 (mar 14) | 2015/Q1 (mar 15) | 2016/Q1 (mar 16) | 2017/Q1 (mar 17) | 2018/Q1 (mar 18) | 2019/Q1 (mar 19) | 2020/Q1 (mar 20) | 2021/Q1 (mar 21) | 2022/Q1 (mar 22) | 2023/Q1 (mar 23) | 2024/Q1 (mar 24) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Data publikacji | 2011-04-28 | 2012-04-26 | 2013-04-25 | 2014-04-28 | 2015-04-30 | 2016-04-29 | 2017-04-27 | 2018-04-25 | 2019-04-25 | 2020-04-25 | 2021-05-12 | 2022-05-10 | 2023-05-11 | 2024-05-14 | |
Przychody ze sprzedaży | 37 772 039 k/k -72.82% | 41 840 726 r/r +10.77% k/k -74.07% | 42 885 188 r/r +2.50% k/k -73.62% | 44 028 072 r/r +2.66% k/k -73.56% | 49 546 413 r/r +12.53% k/k -72.48% | 50 968 964 r/r +2.87% k/k -74.18% | 55 887 031 r/r +9.65% k/k -72.99% | 38 457 273 r/r -31.19% k/k -73.67% | 55 981 420 r/r +45.57% k/k -67.11% | 58 474 294 r/r +4.45% k/k -68.47% | 57 452 178 r/r -1.75% k/k -69.93% | 68 107 948 r/r +18.55% k/k -66.41% | 67 275 770 r/r -1.22% k/k -71.73% | 59 201 889 r/r -12.00% k/k -71.42% | |
Techniczny koszt wytworzenia produkcji sprzedanej | 17 800 800 k/k -73.72% | 19 788 408 r/r +11.17% k/k -75.08% | 20 064 052 r/r +1.39% k/k -74.25% | 20 084 810 r/r +0.10% k/k -75.18% | 22 759 374 r/r +13.32% k/k -73.65% | 21 709 082 r/r -4.61% k/k -75.92% | 22 554 831 r/r +3.90% k/k -74.88% | 12 242 527 r/r -45.72% k/k -74.21% | 22 607 633 r/r +84.66% k/k -69.09% | 21 195 509 r/r -6.25% k/k -71.74% | 21 894 089 r/r +3.30% k/k -75.21% | 24 081 340 r/r +9.99% k/k -68.86% | 26 804 642 r/r +11.31% k/k -71.24% | 23 495 817 r/r -12.34% k/k -72.64% | |
Koszty sprzedaży | 8 613 549 k/k -75.29% | 9 550 872 r/r +10.88% k/k -75.86% | 10 180 324 r/r +6.59% k/k -75.07% | 10 190 486 r/r +0.10% k/k -76.17% | 12 287 445 r/r +20.58% k/k -73.84% | 12 438 118 r/r +1.23% k/k -76.40% | 12 714 257 r/r +2.22% k/k -76.96% | 10 559 127 r/r -16.95% k/k -77.23% | 13 058 747 r/r +23.67% k/k -76.18% | 13 761 603 r/r +5.38% k/k -74.12% | 13 417 004 r/r -2.50% k/k -77.73% | 15 278 810 r/r +13.88% k/k -73.13% | 15 868 647 r/r +3.86% k/k -75.98% | 13 956 421 r/r -12.05% k/k -74.28% | |
Koszty ogólnego zarządu | 4 657 816 k/k -74.98% | 4 765 032 r/r +2.30% k/k -76.77% | 4 962 751 r/r +4.15% k/k -75.12% | 5 159 898 r/r +3.97% k/k -75.69% | 5 884 071 r/r +14.03% k/k -74.03% | 6 859 319 r/r +16.57% k/k -74.77% | 7 300 254 r/r +6.43% k/k -76.16% | 6 173 870 r/r -15.43% k/k -77.33% | 10 860 783 r/r +75.92% k/k -68.33% | 9 632 667 r/r -11.31% k/k -74.60% | 8 574 952 r/r -10.98% k/k -81.43% | 9 840 038 r/r +14.75% k/k -74.45% | 10 421 690 r/r +5.91% k/k -76.39% | 2 507 425 r/r -75.94% k/k -92.63% | |
Zysk ze sprzedaży | 6 699 873 k/k -62.25% | 7 736 414 r/r +15.47% k/k -64.61% | 7 678 061 r/r -0.75% k/k -67.81% | 8 592 878 r/r +11.91% k/k -60.24% | 8 615 523 r/r +0.26% k/k -64.16% | 9 962 446 r/r +15.63% k/k -63.59% | 13 317 689 r/r +33.68% k/k -57.47% | 9 481 751 r/r -28.80% k/k -62.03% | 9 454 257 r/r -0.29% k/k +18.78% | 13 884 515 r/r +46.86% k/k -28.12% | 13 566 133 r/r -2.29% k/k +469.31% | 18 907 760 r/r +39.37% k/k -37.03% | 14 180 792 r/r -25.00% k/k -59.00% | 13 109 143 r/r -7.56% k/k -60.23% | |
Pozostałe przychody operacyjne | 1 023 035 k/k -63.82% | 678 341 r/r -33.69% k/k -82.12% | 672 561 r/r -0.85% k/k -84.81% | 538 098 r/r -19.99% k/k -85.37% | 1 059 051 r/r +96.81% k/k -65.30% | 866 485 r/r -18.18% k/k -81.68% | 738 465 r/r -14.77% k/k -81.41% | 639 692 r/r -13.38% k/k -82.25% | 576 374 r/r -9.90% k/k -97.35% | 1 925 623 r/r +234.09% k/k -72.36% | 1 631 105 r/r -15.29% k/k -77.05% | 2 368 123 r/r +45.19% k/k -65.67% | 1 795 392 r/r -24.19% k/k -87.40% | 1 156 942 r/r -35.56% k/k -85.97% | |
Pozostałe koszty operacyjne | 3 117 246 k/k -68.08% | 1 627 186 r/r -47.80% k/k -77.81% | 952 447 r/r -41.47% k/k -92.12% | 387 931 r/r -59.27% k/k -91.96% | 1 504 752 r/r +287.89% k/k -58.47% | 862 217 r/r -42.70% k/k -84.19% | 907 257 r/r +5.22% k/k -78.04% | 399 808 r/r -55.93% k/k -89.89% | 1 643 097 r/r +310.97% k/k -87.24% | 4 433 940 r/r +169.85% k/k -74.98% | 829 533 r/r -81.29% k/k -98.94% | 1 679 553 r/r +102.47% k/k -92.19% | 2 075 922 r/r +23.60% k/k -86.99% | 967 703 r/r -53.38% k/k -97.49% | |
Zysk operacyjny (EBIT) | 4 605 661 k/k -57.40% | 6 787 570 r/r +47.37% k/k -62.96% | 7 398 175 r/r +9.00% k/k -54.30% | 8 743 045 r/r +18.18% k/k -57.27% | 8 169 822 r/r -6.56% k/k -65.19% | 9 966 714 r/r +21.99% k/k -62.58% | 13 148 897 r/r +31.93% k/k -57.79% | 9 721 635 r/r -26.07% k/k -60.51% | 8 387 535 r/r -13.72% k/k -50.16% | 11 376 198 r/r +35.63% k/k +32.91% | 14 367 705 r/r +26.30% k/k +119.26% | 19 596 330 r/r +36.39% k/k +27.07% | 13 900 262 r/r -29.07% k/k -57.73% | 13 298 383 r/r -4.33% k/k +399.76% | |
Przychody finansowe | 196 583 k/k -87.07% | 461 938 r/r +134.98% k/k -82.15% | 288 241 r/r -37.60% k/k -85.96% | 383 760 r/r +33.14% k/k -76.21% | 49 068 r/r -87.21% k/k -96.64% | 157 931 r/r +221.86% k/k -90.01% | 147 693 r/r -6.48% k/k -77.89% | 1 557 145 r/r +954.31% k/k +29.18% | 731 221 r/r -53.04% k/k -81.31% | 163 883 r/r -77.59% k/k -91.90% | 456 709 r/r +178.68% k/k -88.82% | 311 718 r/r -31.75% k/k -87.12% | 691 974 r/r +121.99% k/k -67.21% | 692 445 r/r +0.07% k/k -73.50% | |
Koszty finansowe | 1 006 987 k/k -80.98% | 1 219 349 r/r +21.09% k/k -79.20% | 1 056 882 r/r -13.32% k/k -77.87% | 1 026 140 r/r -2.91% k/k -77.51% | 1 193 988 r/r +16.36% k/k -78.63% | 1 481 135 r/r +24.05% k/k -74.57% | 1 565 546 r/r +5.70% k/k -72.35% | 1 308 844 r/r -16.40% k/k -80.81% | 2 008 707 r/r +53.47% k/k -81.85% | 3 095 564 r/r +54.11% k/k -62.61% | 1 957 326 r/r -36.77% k/k -77.32% | 2 498 393 r/r +27.64% k/k -71.14% | 2 234 889 r/r -10.55% k/k -81.96% | 2 786 983 r/r +24.70% k/k -76.01% | |
Pozostałe przychody (koszty) | -44 131 k/k +80.10% | -24 970 r/r +43.42% k/k +87.44% | -25 064 r/r -0.38% k/k +86.67% | -20 857 r/r +16.79% k/k +68.57% | 24 534 r/r +217.63% k/k +144.28% | -21 342 r/r -186.99% k/k +44.35% | -54 857 r/r -157.04% k/k +52.31% | 298 804 r/r +644.69% k/k +258.20% | -81 725 r/r -127.35% k/k -127.95% | -36 418 r/r +55.44% k/k -105.34% | -121 168 r/r -232.71% k/k +72.65% | -93 050 r/r +23.21% k/k -141.29% | -172 994 r/r -85.91% k/k +75.41% | -60 213 r/r +65.19% k/k +91.45% | |
Zysk z działalności gospodarczej | 3 751 127 k/k -44.96% | 6 005 189 r/r +60.09% k/k -59.57% | 6 604 469 r/r +9.98% k/k -50.26% | 8 079 808 r/r +22.34% k/k -53.69% | 7 049 436 r/r -12.75% k/k -63.45% | 8 622 168 r/r +22.31% k/k -61.42% | 11 676 187 r/r +35.42% k/k -55.17% | 10 268 740 r/r -12.05% k/k -46.21% | 7 028 324 r/r -31.56% k/k -29.49% | 8 408 098 r/r +19.63% k/k +181.66% | 12 745 921 r/r +51.59% k/k +116.01% | 17 316 605 r/r +35.86% k/k +84.02% | 12 184 353 r/r -29.64% k/k -44.37% | 11 143 632 r/r -8.54% k/k +258.11% | |
Wynik zdarzeń nadzwyczajnych | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Zysk przed opodatkowaniem | 3 751 127 k/k -44.96% | 6 005 189 r/r +60.09% k/k -59.57% | 6 604 469 r/r +9.98% k/k -50.26% | 8 079 808 r/r +22.34% k/k -53.69% | 7 049 436 r/r -12.75% k/k -63.45% | 8 622 168 r/r +22.31% k/k -61.42% | 11 676 187 r/r +35.42% k/k -55.17% | 10 268 740 r/r -12.05% k/k -46.21% | 7 028 324 r/r -31.56% k/k -29.49% | 8 408 098 r/r +19.63% k/k +181.66% | 12 745 921 r/r +51.59% k/k +116.01% | 17 316 605 r/r +35.86% k/k +84.02% | 12 184 353 r/r -29.64% k/k -44.37% | 11 143 632 r/r -8.54% k/k +258.11% | |
Zysk (strata) netto z działalności zaniechanej | 0 | 0 | 0 | 0 | 0 | 166 468 | 417 760 r/r +150.96% k/k -64.76% | 33 668 r/r -91.94% k/k -99.83% | 0 r/r -100.00% | 546 276 k/k -92.45% | 0 r/r -100.00% k/k -100.00% | 0 | 0 | 0 | |
Zysk netto | 2 740 128 k/k -47.18% | 4 332 226 r/r +58.10% k/k -60.32% | 4 854 139 r/r +12.05% k/k -52.43% | 5 944 103 r/r +22.45% k/k -55.01% | 5 352 501 r/r -9.95% k/k -63.53% | 6 748 340 r/r +26.08% k/k -61.36% | 9 583 166 r/r +42.01% k/k -55.11% | 8 223 409 r/r -14.19% k/k -75.64% | 5 316 407 r/r -35.35% k/k -27.74% | 6 773 822 r/r +27.41% k/k -61.30% | 9 740 027 r/r +43.79% k/k +120.13% | 15 325 335 r/r +57.34% k/k +226.03% | 10 201 941 r/r -33.43% k/k -47.78% | 8 610 402 r/r -15.60% k/k +167.31% | |
Zysk netto akcjonariuszy jednostki dominującej | 2 744 140 k/k -46.74% | 4 328 064 r/r +57.72% k/k -60.33% | 4 845 784 r/r +11.96% k/k -51.54% | 5 935 760 r/r +22.49% k/k -55.12% | 5 327 967 r/r -10.24% k/k -63.51% | 6 449 552 r/r +21.05% k/k -63.18% | 8 789 843 r/r +36.29% k/k -56.15% | 8 223 409 r/r -6.44% k/k -73.12% | 5 337 913 r/r -35.09% k/k -26.76% | 6 778 375 r/r +26.99% k/k -61.09% | 9 735 367 r/r +43.62% k/k +120.10% | 15 311 378 r/r +57.28% k/k +232.90% | 10 183 239 r/r -33.49% k/k -47.68% | 8 601 800 r/r -15.53% k/k +167.27% | |
EBITDA | 7 486 205 k/k -69.93% | 9 896 285 r/r +32.19% k/k -67.61% | 10 092 598 r/r +1.98% k/k -64.32% | 11 450 219 r/r +13.45% k/k -64.74% | 11 465 556 r/r +0.13% k/k -68.14% | 14 410 118 r/r +25.68% k/k -64.71% | 16 229 351 r/r +12.62% k/k -65.99% | 11 859 553 r/r -26.93% k/k -66.79% | 13 497 479 r/r +13.81% k/k -69.42% | 17 189 485 r/r +27.35% k/k -45.28% | 19 428 791 r/r +13.03% k/k +244.68% | 24 621 030 r/r +26.72% k/k -16.48% | 20 188 809 r/r -18.00% k/k -68.15% | 18 085 285 r/r -10.42% k/k -60.88% |
Dane kwartalne RZiS oraz CashFlow obliczne są na podstawie publikowanych danych skumulowanych.
Dynamika zmian dla sektora obliczana jest w oparciu o medianę.
Dane w tys. PLN
Informacje
ISIN: | DE000BAY0017 |
---|---|
Liczba akcji: | 826 950 000 |
Kapitalizacja: | 100 887 900 000 |
Enterprise Value: | 285 009 870 000 |
Branża: | Produkcja leków |
Bayer AG to firma naukowo-medyczna. Segmenty Spółki to: farmaceutyki, zdrowie konsumentów, uprawa roślin i zdrowie zwierząt. Segment Pharmaceuticals... Bayer AG to firma naukowo-medyczna. Segmenty Spółki to: farmaceutyki, zdrowie konsumentów, uprawa roślin i zdrowie zwierząt. Segment Pharmaceuticals koncentruje się na badaniach, opracowywaniu i sprzedaży produktów na receptę i specjalistycznych terapii, szczególnie w dziedzinie kardiologii, onkologii, ginekologii, hematologii i okulistyki, a także radiofarmakologii i innych. Segment Consumer Health opracowuje, produkuje i sprzedaje bez recepty produkty dostępne bez recepty w zakresie m.in. dermatologii, suplementów diety, leków przeciwbólowych, przewodu pokarmowego, przeziębienia, alergii, zatok i grypy, pielęgnacji stóp i ochrony przeciwsłonecznej. Segment Crop Science bada, rozwija i wprowadza na rynek rozwiązania i nasiona do ochrony roślin, a także obejmuje spółkę zależną Monsanto. Segment Animal Health zajmuje się opracowywaniem, produkcją i marketingiem weterynaryjnych produktów na receptę i bez recepty.
Nazwa: | BAYER AG |
---|---|
Adres: | Werk Leverkusen, 51-368, Leverkusen, Deutschland |
CEO: | Bill Anderson |
Telefon: | +49 (0) 214 30-1 |
WWW: | http://www.bayer.com/ |